EB-1B Petition Approved for Research Associate in New York in the Field of Pharmacology
Client’s Testimonial:
Thank you very much for this wonderful news. I would simply say you made everything possible for me. Your way of [presentation] of all the documents to [USCIS] and prompt response is spectacular. I strongly recommend you to each and every person who wants to file for EB-1.
We Received EB-1B Approval for a Research Associate in the Field of Pharmacology on May 8, 2015 (Approval Notice)
General Field: Pharmacology
Position at the Time of Case Filing: Research Associate
Petitioner: University
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: May 8, 2015
Processing Time: 22 Days (Premium Processing Requested After 15 Days)
Case Summary:
At North America Immigration Law Group, we recently received an EB-1B approval for a Research Associate in the field of Pharmacology. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB-1B petition. His specialized research has focused on identifying novel ways to treat diabetes and preterm births. His research work had resulted in 6 peer-reviewed scientific articles. He had also reviewed 45 manuscripts for journals at the time we filed the case. Furthermore, the beneficiary had a total of 124 citations to his work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. The petitioner in this case was a University. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “[Client]’s study presents the field of pharmacology with indispensable data that paves the way for new and successful treatments for one of America’s most common health conditions. Surely, work of this nature is in high demand, and scientists who commit their careers to it represent a national asset.” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. With the proof and documentation that we provided, his case was approved in 22 days.

